wesley
rd
wood
rd
correa
enjuan
l
lack
protect
vivo
neutral
monoclon
antibodi
transmiss
gastroenter
viru
vet
microbiol
monoclon
antibodi
mab
specif
surfac
glycoprotein
transmiss
gastroenter
viru
tgev
swine
examin
either
alon
combin
evalu
potenti
valu
protect
neonat
pig
lethal
dose
tgev
cesareandeliv
colostrumdepriv
cdcd
piglet
given
one
prechalleng
dose
mab
equal
dose
mab
success
feed
challeng
vivo
challeng
result
demonstr
neither
mab
given
individu
combin
mab
abl
protect
neonat
pig
lethal
dose
tgev
howev
parallel
experi
polyclon
antibodi
immun
colostrum
serum
protect
envelop
coronaviru
transmiss
gastroenter
viru
tgev
contain
surfac
elmatrix
glycoprotein
phosphoryl
nucleocapsid
protein
close
associ
positivestrand
rna
genom
garw
pocock
brian
et
al
hu
et
al
larg
protein
protrud
clubshap
project
viru
surfac
contain
neutral
antigen
determin
garw
et
al
hu
et
al
glycoprotein
deepli
embed
lipid
envelop
predomin
surfac
protein
coronavirus
includ
tgev
sturman
et
al
wesley
wood
competit
inhibit
studi
monoclon
antibodi
mab
reveal
one
domin
neutral
site
site
tgev
wherea
neutral
mab
one
nonsit
domain
occur
lower
frequenc
jimenez
et
al
delma
et
al
correa
et
al
wood
et
al
shown
mab
neutral
tgev
presenc
guinea
pig
rabbit
swine
complement
c
tgev
lead
caus
neonat
death
swine
first
week
postparturit
passiv
immun
colostrum
postcolostr
milk
immun
sow
crucial
provid
immedi
protect
neonat
tgev
infect
oral
infect
pregnant
sow
establish
high
level
secretori
iga
siga
colostrum
postcolostr
milk
igg
slga
immunoglobulin
fraction
colostrum
postcolostr
milk
immun
sow
protect
measur
amount
fed
suscept
piglet
stone
et
al
purpos
paper
determin
murin
mab
neutral
tgev
cell
cultur
also
protect
babi
pig
identif
protect
mab
direct
singl
epitop
combin
ofepitop
essenti
develop
immunoprophylat
measur
virul
pigpass
tgev
miller
strain
kindli
provid
dr
linda
saif
ohio
agricultur
research
develop
center
wooster
oh
stock
challeng
viru
prepar
oral
infect
seven
cesareandeliv
colostrumdepriv
cdcd
piglet
harvest
small
intestin
onset
diarrhea
h
postinfect
frozen
small
intestin
combin
homogen
ware
blender
cold
filter
steril
gauz
homogen
supernat
ml
mix
ml
fetal
bovin
serum
aliquot
store
liquid
nitrogen
thaw
aliquot
stock
challeng
viru
plaqu
titer
plaqueform
unit
pfu
swine
testicular
st
cell
cdcd
piglet
obtain
sow
seroneg
tgev
neutral
antibodi
plaqu
reduct
assay
st
cell
piglet
hous
individu
plexiglass
isol
room
maintain
c
isol
chamber
kept
slight
neg
pressur
minim
contamin
atom
viru
cow
milk
treat
flpropiolacton
final
concentr
aliquot
dispens
steril
liter
bottl
allow
stand
room
temperatur
least
overnight
use
amtow
calhoon
daili
ration
flpropiolactonetr
cow
milk
divid
three
feed
first
day
gradual
increas
ml
per
feed
day
appropri
antibodi
supplement
morn
feed
prior
challeng
piglet
continu
fed
either
mab
colostrum
hyperimmun
antiserum
maxim
protect
effect
antibodi
challeng
dose
incub
vitro
h
excess
antibodi
follow
experi
random
aliquot
challeng
viru
thaw
mix
dilut
pb
viru
sonic
two
burst
order
disrupt
viru
aggreg
sonic
viru
dilut
media
gibco
laboratori
grand
island
ny
supplement
fetal
bovin
serum
final
dilut
either
dilut
viru
ml
incub
h
equal
volum
colostrum
hyperimmun
antiserum
mab
either
without
guinea
pig
serum
sourc
unit
c
virusantiserum
viruscolostrum
virusmab
inocula
neg
titer
st
cell
control
anim
receiv
ml
challeng
viru
incub
h
equal
volum
media
contain
fetal
bovin
serum
lieu
afternoon
feed
experiment
pig
given
challeng
viru
plu
antibodi
mixtur
stomach
tube
even
regular
feed
resum
time
per
day
schedul
appropri
feed
supplement
follow
amount
antibodi
ml
colostrum
viru
neutral
vn
titer
ml
antiserum
vn
titer
ml
mab
vn
titer
presenc
unit
c
ml
mab
vn
titer
ml
mab
vn
titer
pig
observ
onset
clinic
sign
death
day
follow
challeng
vn
titer
determin
plaquereduct
assay
wood
et
al
mab
direct
tgev
mab
isotyp
igg
mab
isotyp
igg
mab
isotyp
igg
structur
protein
prepar
essenti
describ
van
deusen
whetston
primari
hybridoma
secret
antibodi
clone
twice
administ
intraperiton
pristineprim
balbc
mice
result
ascit
fluid
ml
per
mab
collect
pool
clarifi
min
heat
inactiv
min
use
obtain
colostr
whey
pregnant
sow
seroneg
tgev
traliz
antibodi
inocul
orallynas
week
prior
farrow
singl
dose
intestin
homogen
contain
miller
viru
fever
diarrhea
occur
follow
inocul
howev
sow
feed
day
colostrum
ml
collect
time
farrow
ml
h
farrow
milk
letdown
unit
oxytocin
techamerica
elwood
ks
given
intraven
eolostrum
centrifug
g
min
whey
store
aliquot
c
tge
immun
serum
kindli
provid
dr
aw
mcclurkin
nation
anim
diseas
center
ame
ia
prepar
follow
two
dose
virul
tgev
administ
pregnant
sow
week
prior
farrow
dose
given
intramuscularli
consist
part
sucros
gradientpurifi
viru
part
adjuv
part
miner
oil
part
arlacel
sigma
chemic
co
st
loui
mo
second
day
postfarrow
piglet
expos
piginfecti
dose
tgev
intestin
homogen
sign
diseas
observ
either
pig
sow
fourteen
day
later
piglet
remov
sow
given
intraven
dose
week
apart
ml
viru
without
adjuv
seven
day
last
inject
sow
anesthet
bled
specif
mab
determin
radioimmunoprecipit
procedur
previous
describ
wesley
wood
mab
test
tgevinfect
st
cell
lysat
label
mock
lysat
control
mab
purifi
high
pressur
liquid
chromatographi
hplc
ascit
fluid
deschamp
et
al
lesilabel
greenwood
et
al
inhibit
bind
purifi
viru
unlabel
mab
studi
radioimmunoassay
ria
describ
correa
et
al
studi
perform
standard
mab
repres
antigen
site
protein
site
site
b
site
c
site
order
ensur
uniform
viru
challeng
dose
aliquot
pigpropag
virul
tgev
miller
strain
store
liquid
nitrogen
experi
random
aliquot
thaw
mix
sonic
prior
dilut
tissu
cultur
medium
titer
challeng
viru
assay
st
cell
pfu
determin
piglet
ldso
challeng
viru
survivor
ld
estim
method
reed
muench
cdcd
piglet
inocul
via
stomach
tube
ml
serial
dilut
challeng
viru
number
survivor
record
day
tabl
piglet
ldso
estim
challeng
dose
select
ldo
dilut
pfu
ldo
dilut
challeng
dose
purpos
kept
low
vast
antibodi
surplu
vitro
incub
viru
overwhelm
posit
effect
produc
effect
neutral
tgev
antibodi
three
differ
tgev
neutral
mab
select
test
abil
protect
babi
pig
vivo
two
mab
direct
protein
shown
fig
elmatrix
protein
fig
neutral
tgev
presenc
complement
wood
et
al
determin
epitop
specif
oneway
competit
inhibit
experi
carri
figur
show
neutral
mab
direct
antigen
site
predomin
neutral
site
protein
correa
et
al
contrast
neither
mab
mab
inhibit
bind
mab
correa
et
al
shown
repres
antigen
site
b
c
result
suggest
mab
neutral
tgev
interact
differ
epitop
protein
ascit
fluid
contain
mab
effici
neutral
tgev
vitro
presenc
c
wood
et
al
complementdepen
guinea
pig
serum
final
concentr
use
sourc
unit
c
hthe
amount
type
mab
supplement
feed
challeng
feed
challeng
observ
period
dent
neutral
mechan
could
irrevers
caus
hole
produc
viru
envelop
virolysi
c
coat
outer
surfac
viru
determin
vivo
protect
capac
complementdepend
mechan
neutral
mab
test
piglet
differ
way
tabl
one
group
pig
challeng
viru
incub
mab
alon
second
group
challeng
viru
treat
mab
plu
unit
complement
c
third
group
likewis
receiv
mab
unit
c
treat
viru
ml
mab
fed
time
per
day
durat
experi
piglet
receiv
mab
inoculum
either
without
c
fulli
suscept
infect
even
though
viru
detect
mab
c
inoculum
thu
even
though
tissu
cultur
assay
show
viru
neutral
mab
c
piglet
remain
fulli
suscept
challeng
indic
c
irrevers
neutral
virul
viru
neutral
mab
use
alon
group
iv
mab
use
combin
complementdepend
mab
group
v
inactiv
viru
prior
challeng
tabl
although
mab
complet
neutral
inoculum
vitro
acut
clinic
sign
diarrhea
dehydr
depress
develop
pig
receiv
mabtreat
viru
mab
group
pig
surviv
challeng
ldso
show
mark
clinic
sign
emaci
dehydr
mab
pig
surviv
ldo
challeng
dose
complementdepend
antibodi
plu
unit
c
complementindepend
antibodi
incub
simultan
challeng
viru
group
v
tabl
addit
mab
ml
supplement
feed
combin
effect
mab
c
concentr
neutral
tgev
vitro
prevent
morbid
reduc
mortal
piglet
ensur
feed
schedul
environment
condit
within
piglet
isol
chamber
satisfactori
surviv
polyclon
antibodi
given
immun
colostrum
hyperimmun
antiserum
use
instead
neutral
mab
challeng
viru
ldso
incub
vitro
either
colostrum
group
hyperimmun
serum
group
ii
administ
stomach
tube
tabl
posit
control
anim
receiv
addit
colostrum
ml
antiserum
ml
feed
piglet
receiv
viru
treat
either
colostrum
immun
serum
remain
healthi
alert
postchalleng
period
howev
one
piglet
colostrum
treatment
group
group
die
suddenli
day
postchalleng
pig
show
sign
diarrhea
die
necropsi
intestin
appear
normal
tgev
recov
intestin
content
suggest
pig
die
caus
tgev
infect
addit
evid
suggest
piglet
immun
serum
group
group
ii
complet
protect
infect
challeng
viru
end
postchalleng
observ
period
piglet
group
ii
combin
singl
pen
surviv
piglet
shown
clinic
sign
tge
week
follow
common
hous
piglet
immun
serum
group
develop
diarrhea
die
convalesc
piglet
surviv
origin
challeng
continu
recov
postchalleng
day
serum
neutral
titer
appar
one
convalesc
piglet
shed
viru
time
piglet
acolostrum
antiserum
incub
vitro
viru
h
c
prior
babi
pig
challeng
one
pig
healthi
day
postchalleng
becam
weak
lost
appetit
found
dead
next
morn
tgev
recov
intestin
content
transfer
singl
pen
similar
experi
colostrum
control
pig
group
carri
polyclon
antibodi
monoclon
antibodi
mab
neutral
porcin
tge
coronaviru
vitro
direct
glycoprotein
garw
et
al
jimenez
et
al
delma
et
al
elmatrix
glycoprotein
abund
glycoprotein
viru
envelop
elspecif
mab
exhibit
complementdepend
viru
neutral
vn
titer
exceed
commonli
associ
protect
hyperimmun
sera
mab
wood
et
al
test
potent
neutral
mab
mab
presenc
c
determin
capac
passiv
protect
piglet
pig
inocul
viru
treat
elspecif
mab
unit
c
mab
addit
mab
fed
flpropiolactonetr
milk
time
daili
observ
period
studi
shown
mab
c
mixtur
neutral
tgev
vitro
protect
babi
pig
addit
neither
elspecif
mabc
mixtur
supplement
neutral
mab
neutral
mab
alon
protect
piglet
therefor
effici
viru
neutral
vitro
correl
abil
protect
piglet
tgev
challeng
whether
fraction
virul
viru
escap
neutral
viru
antibodi
complex
dissoci
alimentari
tract
current
investig
protect
tge
mortal
piglet
result
neutral
viru
antibodi
lumen
alimentari
tract
haelterman
accomplish
natur
continu
immunoglobulin
intak
colostrum
milk
immun
sow
piglet
depriv
immunoglobulin
sourc
suscept
experiment
infect
within
h
remov
sow
haelterman
colostr
igg
siga
immun
sow
passiv
protect
piglet
abouyoussef
ristic
bohl
saif
stone
et
al
although
siga
superior
persist
high
titer
postcolostr
milk
porter
allen
haelterman
shown
antiserum
sow
expos
virul
tgev
also
suffici
passiv
protect
piglet
fact
one
report
suggest
antiserum
administ
piglet
clinic
sign
tge
alter
outcom
diseas
nobl
therefor
antiserum
colostrum
immun
sow
fed
regularli
piglet
critic
protect
epitop
virul
tgev
neutral
lumen
alimentari
tract
repeat
result
cdcd
piglet
isol
chamber
fed
aliquot
colostrum
per
feed
ml
antiserum
per
feed
three
daili
feed
protect
pig
challeng
viru
first
incub
c
h
antibodi
polyclon
serum
complet
block
infect
tgev
piglet
fed
hyperimmun
antiserum
challeng
viru
fulli
suscept
week
age
hous
convalesc
pig
shed
tgev
sinc
antibodi
critic
protect
epitop
present
immun
colostrum
antiserum
appropri
mab
combin
mab
show
parallel
degre
passiv
protect
would
identifi
critic
epitop
mous
ascit
fluid
contain
complementdepend
elspecif
mab
complementindepend
mab
prevent
morbid
reduc
mortal
piglet
mab
may
reduc
mortal
lower
challeng
dose
tabl
diminish
observ
clinic
sign
one
explan
lack
passiv
protect
murin
mab
may
virusantibodi
complex
dissoci
pass
stomach
piglet
liber
infecti
viru
howev
porcin
polyclon
antibodi
colostrum
hyperimmun
antiserum
appar
dissoci
effect
inactiv
tgev
protect
piglet
haelterman
stone
et
al
result
suggest
perhap
antigen
avid
murin
mab
use
studi
inadequ
surviv
passag
piglet
digest
tract
wherea
avid
pig
polyclon
antibodi
suffici
second
explan
lack
protect
neutral
mab
could
small
fraction
viru
may
escap
neutral
mab
specif
viru
variant
present
challeng
viru
inoculum
limit
effect
viru
variant
might
escap
neutral
minim
challeng
dose
ldso
use
viru
escap
detect
plaqu
assay
vitro
incub
challeng
inoculum
mab
signific
differ
onset
clinic
diseas
experiment
piglet
inoculum
incub
mab
control
piglet
addit
attempt
minim
effect
viru
aggreg
challeng
viru
sonic
vitro
incub
expos
infecti
particl
mab
final
explan
lack
passiv
protect
may
mab
studi
although
neutral
vitro
direct
viral
epitop
critic
protect
target
cell
piglet
ie
viral
neutral
epitop
caus
plaqu
reduct
st
cell
vitro
may
differ
viral
receptor
site
involv
tge
viral
entri
replic
swine
intestin
enterocyt
thu
lead
cell
cytopatholog
clinic
diseas
piglet
viru
appar
neutral
mab
assay
st
cell
neutral
assay
vivo
addit
studi
need
determin
may
import
differ
tgev
replic
st
cell
vitro
natur
target
cell
hostswin
intestin
enterocyt
